ATPAF2 Antibody
- 
								中文名稱:ATPAF2兔多克隆抗體
- 
								貨號:CSB-PA002425GA01HU
- 
								規(guī)格:¥3,900
- 
								其他:
產(chǎn)品詳情
- 
											Uniprot No.:
- 
											基因名:ATPAF2
- 
											別名:ATPAF2 antibody; ATP12 antibody; LP3663ATP synthase mitochondrial F1 complex assembly factor 2 antibody; ATP12 homolog antibody
- 
											宿主:Rabbit
- 
											反應種屬:Human,Mouse,Rat
- 
											免疫原:Human ATPAF2
- 
											免疫原種屬:Homo sapiens (Human)
- 
											抗體亞型:IgG
- 
											純化方式:Antigen Affinity Purified
- 
											濃度:It differs from different batches. Please contact us to confirm it.
- 
											保存緩沖液:PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
- 
											產(chǎn)品提供形式:Liquid
- 
											應用范圍:ELISA,WB,IHC
- 
											Protocols:
- 
											儲存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
- 
											貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
- 
											用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關產(chǎn)品
靶點詳情
- 
											功能:May play a role in the assembly of the F1 component of the mitochondrial ATP synthase (ATPase).
- 
											基因功能參考文獻:- Two possible dementia susceptibility genes including ATPAF2 and TOM1L2 near SREBF1 locus were identified. PMID: 20167577
- Data show that wild type human Atp12p rescues the respiratory defect of a yeast ATP12 deletion mutant (Deltaatp12). PMID: 19933271
 
- 
											相關疾?。?/div>Mitochondrial complex V deficiency, nuclear 1 (MC5DN1)亞細胞定位:Mitochondrion.蛋白家族:ATP12 family組織特異性:Widely expressed.數(shù)據(jù)庫鏈接:
Most popular with customers
- 
                                            
- 
                                            YWHAB Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC, IF, FC Species Reactivity: Human, Mouse, Rat 
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
 
 













 
         
           
  
          